BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 20694815)

  • 41. Physical, morphological and functional differences between ph 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Abeta.
    Wood SJ; Maleeff B; Hart T; Wetzel R
    J Mol Biol; 1996 Mar; 256(5):870-7. PubMed ID: 8601838
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of ionic strength on the aggregation kinetics of the amidated amyloid beta peptide Aβ (1-40) in aqueous solutions.
    Campos-Ramírez A; Márquez M; Quintanar L; Rojas-Ochoa LF
    Biophys Chem; 2017 Sep; 228():98-107. PubMed ID: 28587777
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Steady-state and time-resolved Thioflavin-T fluorescence can report on morphological differences in amyloid fibrils formed by Aβ(1-40) and Aβ(1-42).
    Lindberg DJ; Wranne MS; Gilbert Gatty M; Westerlund F; Esbjörner EK
    Biochem Biophys Res Commun; 2015 Mar; 458(2):418-23. PubMed ID: 25660454
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Different effects of Alzheimer's peptide Aβ(1-40) oligomers and fibrils on supported lipid membranes.
    Canale C; Seghezza S; Vilasi S; Carrotta R; Bulone D; Diaspro A; San Biagio PL; Dante S
    Biophys Chem; 2013 Dec; 182():23-9. PubMed ID: 23998637
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Negatively charged gold nanoparticles inhibit Alzheimer's amyloid-β fibrillization, induce fibril dissociation, and mitigate neurotoxicity.
    Liao YH; Chang YJ; Yoshiike Y; Chang YC; Chen YR
    Small; 2012 Dec; 8(23):3631-9. PubMed ID: 22915547
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of phenolic OH groups of flavonoid compounds with H-bond formation ability to suppress amyloid mature fibrils by destabilizing β-sheet conformation of monomeric Aβ17-42.
    Andarzi Gargari S; Barzegar A; Tarinejad A
    PLoS One; 2018; 13(6):e0199541. PubMed ID: 29953467
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amyloid β 42 fibril structure based on small-angle scattering.
    Lattanzi V; André I; Gasser U; Dubackic M; Olsson U; Linse S
    Proc Natl Acad Sci U S A; 2021 Nov; 118(48):. PubMed ID: 34815346
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preparation of Amyloid Fibrils Seeded from Brain and Meninges.
    Scherpelz KP; Lu JX; Tycko R; Meredith SC
    Methods Mol Biol; 2016; 1345():299-312. PubMed ID: 26453221
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fibrillar oligomers nucleate the oligomerization of monomeric amyloid beta but do not seed fibril formation.
    Wu JW; Breydo L; Isas JM; Lee J; Kuznetsov YG; Langen R; Glabe C
    J Biol Chem; 2010 Feb; 285(9):6071-9. PubMed ID: 20018889
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structure-activity relationships in peptide modulators of β-amyloid protein aggregation: variation in α,α-disubstitution results in altered aggregate size and morphology.
    Bett CK; Ngunjiri JN; Serem WK; Fontenot KR; Hammer RP; McCarley RL; Garno JC
    ACS Chem Neurosci; 2010 Sep; 1(9):608-26. PubMed ID: 22778850
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage.
    Ferrera D; Mazzaro N; Canale C; Gasparini L
    Neurobiol Aging; 2014 Nov; 35(11):2444-2457. PubMed ID: 24973120
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Critical role of interfaces and agitation on the nucleation of Abeta amyloid fibrils at low concentrations of Abeta monomers.
    Morinaga A; Hasegawa K; Nomura R; Ookoshi T; Ozawa D; Goto Y; Yamada M; Naiki H
    Biochim Biophys Acta; 2010 Apr; 1804(4):986-95. PubMed ID: 20100601
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nanoscale Infrared Spectroscopy Identifies Parallel to Antiparallel β-Sheet Transformation of Aβ Fibrils.
    Banerjee S; Baghel D; Hasan Ul Iqbal M; Ghosh A
    J Phys Chem Lett; 2022 Nov; 13(45):10522-10526. PubMed ID: 36342244
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering.
    Sandberg A; Luheshi LM; Söllvander S; Pereira de Barros T; Macao B; Knowles TP; Biverstål H; Lendel C; Ekholm-Petterson F; Dubnovitsky A; Lannfelt L; Dobson CM; Härd T
    Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15595-600. PubMed ID: 20713699
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Different Aggregation Pathways and Structures for Aβ40 and Aβ42 Peptides.
    Wang L; Eom K; Kwon T
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33573350
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Unique molecular signatures of Alzheimer's disease amyloid β peptide mutations and deletion during aggregate/oligomer/fibril formation.
    Poduslo JF; Howell KG
    J Neurosci Res; 2015 Mar; 93(3):410-23. PubMed ID: 25377128
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preparation and Fractionation of Heterogeneous Aβ42 Oligomers with Different Aggregation Properties.
    Chen EW; Guo Z
    Methods Mol Biol; 2023; 2551():29-39. PubMed ID: 36310194
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Copper prevents amyloid-β(1-42) from forming amyloid fibrils under near-physiological conditions in vitro.
    Mold M; Ouro-Gnao L; Wieckowski BM; Exley C
    Sci Rep; 2013; 3():1256. PubMed ID: 23409247
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Amide solvent protection analysis demonstrates that amyloid-beta(1-40) and amyloid-beta(1-42) form different fibrillar structures under identical conditions.
    Olofsson A; Lindhagen-Persson M; Sauer-Eriksson AE; Ohman A
    Biochem J; 2007 May; 404(1):63-70. PubMed ID: 17280549
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo.
    Yang F; Lim GP; Begum AN; Ubeda OJ; Simmons MR; Ambegaokar SS; Chen PP; Kayed R; Glabe CG; Frautschy SA; Cole GM
    J Biol Chem; 2005 Feb; 280(7):5892-901. PubMed ID: 15590663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.